Can Arrowhead Pharmaceuticals Inc (ARWR) Stock Rise to the Top of Healthcare Sector Friday?

A rating of 75 puts Arrowhead Pharmaceuticals Inc (ARWR) near the top of the Healthcare sector according to InvestorsObserver. Arrowhead Pharmaceuticals Inc's score of 75 means that it ranks higher than 75% of stocks in the sector. In addition, its overall score of 43 ranks it higher than 43% of all stocks.

ARWR has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on ARWR!

See Full ARWR Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Arrowhead Pharmaceuticals Inc Stock Today?

Arrowhead Pharmaceuticals Inc (ARWR) stock is down -1.46% while the S&P 500 is higher by 1.67% as of 3:39 PM on Friday, Sep 9. ARWR has fallen -$0.57 from the previous closing price of $39.17 on volume of 331,345 shares. Over the past year the S&P 500 is lower by -9.35% while ARWR has fallen -40.88%. ARWR lost -$1.48 per share the over the last 12 months. Click Here to get the full Stock Report for Arrowhead Pharmaceuticals Inc stock.